poisar

Stocks · News reference

8-K filing — ARTELO BIOSCIENCES, INC. (ARTL)

SEC EDGARSEC EDGAR

Filed: 2026-10-09 AccNo: 0001640334-26-001665 Size: 143 KB Item 8.01: Other Events

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
edgar
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. BenzingaHenry Khederian

    Artelo Biosciences (ARTL) Stock Surges Wednesday: What's Happening?

    Artelo Biosciences, Inc. (NASDAQ: ARTL) shares are surging Wednesday afternoon after the clinical-stage biopharmaceutical company announced the filing of a new provisional patent application covering its drug candidate ART27.13 for the treatment of obesity.